Revised 03-26-2008 Euler GL, LU P, Singleton JA.
CDC/NCIRD

Vaccination coverage among U.S. adults 
National Immunization Survey –Adult, 2007* (n=7055)
						
Vaccination: Influenza, 2006-07 season	
Population: 18-49  HR
N: 309
Weighted Coverage: 37.3%
95%  CI: 29.6, 45.7
		
Population: Whites
N: 123
Weighted Coverage: 40.9%
95%  CI: 30.0, 51.7
			
Population: Blacks
N: 87
Weighted Coverage: 30.5%
95%  CI: 17.8, 47.2
					
Population: Hispanics
N: 76
Weighted Coverage: 25.6%
95%  CI: 15.1, 40.1						

Population: 50-64   ALL
N: 2073
Weighted Coverage: 42.2%
95%  CI: 39.0, 45.5
					
Population: Whites
N: 714
Weighted Coverage: 43.1%
95%  CI: 38.7, 47.6
		
Population: Blacks
N: 688
Weighted Coverage: 37.2%
95%  CI: 32.3, 42.5
										
Population: Hispanics
N: 501
Weighted Coverage: 36.1%
95%  CI: 30.5, 42.1
											
Population: 65+  ALL
N: 3087
Weighted Coverage: 68.8%
95%  CI: 65.9, 71.6

Population: Whites
N: 793
Weighted Coverage: 69.4%
95%  CI: 65.6, 73.0

Population: Blacks
N: 1320
Weighted Coverage: 54.6%
95%  CI: 51.3, 57.9

Population: Hispanics
N: 785
Weighted Coverage: 67.2%
95%  CI: 62.5, 71.6


Vaccination: Pneumococcal, ever
Population: 18-64  HR
N: 710
Weighted Coverage: 32.8%
95%  CI: 27.1, 39.0

Population: Whites
N: 231
Weighted Coverage: 34.0%
95%  CI: 26.7, 42.0

Population: Blacks	
N: 244
Weighted Coverage: 26.6%
95%  CI: 18.7, 36.2
			
Population: Hispanics 
N: 174
Weighted Coverage: 18.8%
95%  CI: 12.7, 27.0

Population: 65+  ALL
N: 3009
Weighted Coverage: 65.6%
95%  CI: 62.6, 68.6

Population: Whites
N: 781
Weighted Coverage: 67.8%	
95%  CI: 63.8, 71.5

Population: Blacks
N: 1274
Weighted Coverage: 52.5%
95%  CI: 49.0, 55.9

Population: Hispanics
N: 766
Weighted Coverage: 51.3%
95%  CI: 46.6, 55.9

Vaccination: Tetanus in past 10 years
Population: 18-49  ALL
N: 1738
Weighted Coverage: 57.2%
95%  CI: 54.0, 60.5

Population: Whites
N: 686
Weighted Coverage: 60.0%
95%  CI: 55.5, 64.2

Population: Blacks	
N: 344
Weighted Coverage: 52.9%
95%  CI: 44.8, 60.7	

Population: Hispanics
N: 558
Weighted Coverage: 51.5%
95%  CI: 45.4, 57.6

Population: 50-64  ALL
N: 1957
Weighted Coverage: 57.2%
95%  CI: 53.8, 60.5

Population: Whites
N: 681
Weighted Coverage: 59.1%
95%  CI: 54.6, 63.5

Population: Blacks
N: 648
Weighted Coverage: 48.1%
95%  CI: 42.6, 53.6

Population: Hispanics
N: 467
Weighted Coverage: 54.6%
95%  CI: 47.7, 61.4

Population: 65+   ALL
N: 2802
Weighted Coverage: 44.1%
95%  CI: 40.7, 47.6

Population: Whites
N: 737
Weighted Coverage: 44.7%
95%  CI: 40.3, 49.4

Population: Blacks
N: 1176
Weighted Coverage: 34.3%
95%  CI: 31.3, 37.6

Population: Hispanics
N: 722
Weighted Coverage: 43.0%
95%  CI: 37.9, 48.3

Vaccination: Tdap in past 2 years
Population: 18-64  ALL
N: 3525
Weighted Coverage: 2.1%
95%  CI: 1.5, 2.9

Population: Whites
N: 1294
Weighted Coverage: 1.7%
95%  CI: 1.1, 2.7

Population: Blacks
N: 951
Weighted Coverage: 3.9% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 1.7, 8.9

Population: Hispanics
N: 978
Weighted Coverage: 1.8% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 1.0, 3.0

Vaccination: Tdap proportion of tetanus vaccinations in past 2 years
Population: 18-64   ALL
N: 324
Weighted Coverage: 20.7%
95%  CI: 15.0, 27.7

Population: Whites	
N: 121
Weighted Coverage: 17.5%
95%  CI: 11.0, 26.6
			
Population: Blacks
N: 90
Weighted Coverage: 29.4% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 13.2, 53.4

Population: Hispanics
N: 82
Weighted Coverage: 19.4%
95%  CI: 10.9, 32.2

Vaccination: Zoster/Shingles, ever
Population: 50-59  ALL
N: 1419
Weighted Coverage: 0.8% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.3, 1.8

Population: Whites
N: 492
Weighted Coverage:  0.6% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.2, 1.8

Population: Blacks
N: 477
Weighted Coverage: 1.0% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.4, 2.4

Population: Hispanics
N: 337
Weighted Coverage: 0.4% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.1, 1.4

Population: 60+  ALL
N: 3662
Weighted Coverage: 1.9%
95%  CI: 1.3, 2.8
 
Population: Whites
N: 998
Weighted Coverage: 2.0%
95%  CI: 1.2, 3.3

Population: Blacks
N: 1484 
Weighted Coverage: 2.4% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 1.3, 4.6

Population: Hispanics
N: 940
Weighted Coverage: 1.1% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.5, 2.3

Vaccination: HepA-2 + doses, ever
Population: 18-49  ALL
N: 1629
Weighted Coverage: 12.1%
95%  CI: 9.8, 14.7

Population: Whites
N: 651
Weighted Coverage: 12.5%
95%  CI: 9.5, 16.2

Population: Blacks
N: 331
Weighted Coverage: 10.6%
95%  CI: 6.1, 17.7

Population: Hispanics
N: 506
Weighted Coverage: 7.1% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 4.3, 11.6

Vaccination: HepB-3 + doses, ever
Population: 18-49  ALL
N: 1646
Weighted Coverage: 23.4%
95%  CI: 20.5, 26.5

Population: Whites
N: 660
Weighted Coverage: 24.7%
95%  CI: 20.8, 29.1

Population: Blacks
N: 333
Weighted Coverage: 21.9%
95%  CI: 15.6, 29.8

Population: Hispanics
N: 510
Weighted Coverage: 15.7%
95%  CI: 11.7, 20.8

Vaccination: HPV-1+ doses, ever	
Population: 18-26  Female
N: 167
Weighted Coverage: 9.9% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 4.9, 19.0

Population: Whites
N: 47
Weighted Coverage: 10.5% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 3.7, 26.2

Population: Blacks
N: 33
Weighted Coverage: 18.7% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 6.1, 44.7

Population: Hispanics
N: 70
Weighted Coverage: 1.1% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.2, 7.7

Population: 27-49  Female
N: 924
Weighted Coverage: 1.1% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.4, 3.0

Population: Whites
N: 359
Weighted Coverage: 1.3 (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.3, 4.7	

Population: Blacks
N: 199
Weighted Coverage: 2.6% (The estimate of coverage is unreliable by definition; relative standard error is greater than 0.30 of the estimate.)
95%  CI: 0.8, 8.5

Population: Hispanics
N: 283
Weighted Coverage: 0.0%
95%  CI: Not applicable	

________________________________________________________________________

*NIS-Adult was a landline telephone survey conducted during May, June, July and August 2007.  The sample was selected at random from two national lists of household telephone numbers.  (One list was age-group and racial/ethnic group-specific of respondents to the National Health Interview Survey. The other list was provided by a subcontractor, Survey Sampling International and was age-group-specific.) Vaccinations were self-reported and not validated by comparing to the respondent’s medical chart.  The interview completion rate was 74% with a 64% resolution rate and a 64% screening rate for a CASRO rate of 31%.  (“CASRO” stands for Council of American Survey Research Organizations, which defined a standardized overall response rate for telephone surveys that is the product of three specific rates—interview completion rate, resolution rate, and screening rate.) Before analysis the data were weighted to adjust for non-response, households that do not have a landline telephone or do not have a telephone, and to match the age, gender and racial/ethnic distribution of the country. The contracting survey company was the National Opinion Research Center (NORC) at the University of Chicago. 
n = Actual sample size
CI = Confidence interval  
HR = High risk
Whites = non-Hispanic white persons
Blacks = non-Hispanic black or African-American persons
Tdap = Tetanus-diphtheria acellular pertussis vaccine
HepA-2+ = Two or more doses of hepatitis A vaccine
HepB-3+ = Three or more doses of hepatitis B vaccine
HPV-1+ = One or more doses of human papillomavirus vaccine 

















Location of this document on CDC website:
http://www.cdc.gov/vaccines/stats-surv/nis/downloads/nis-adult-summer-2007.txt